Key result
Diuretic resistance occurs in approximately one out of three patients with congestive heart failure on diuretic therapy, driven by pharmacokinetic and pharmacodynamic alterations.
Understanding and overcoming diuretic resistance is pivotal for improving symptomatic management and quality of life in patients with congestive heart failure.
Answers are grounded in this paper and cite their sources.
Diuretic braking may affect ~1/3 of CHF patients; leaves open optimal mitigation strategies.
Congestive heart failure is a complex clinical hemodynamic disorder characterized by chronic and progressive pump failure and fluid accumulation. Although the overall impact of diuretic therapy on congestive heart failure mortality remains unknown, diuretics remain a vital component of symptomatic congestive heart failure management. Over time, sodium and water excretion are equalized before adequate fluid elimination occurs. This phenomenon is thought to occur in one out of three patients with congestive heart failure on diuretic therapy and is termed diuretic resistance. In congestive heart failure, both pharmacokinetic and pharmacodynamic alterations are thought to be responsible for diuretic resistance. Due to disease chronicity, symptomatic management is vital to improved quality of life and enhancing diuretic response is therefore pivotal.
No takes yet. Share an insight, caveat, or question.
Ravnan et al. (2002) conducted a review in Congestive heart failure. Diuretic therapy was evaluated. Diuretic resistance occurs in approximately one out of three patients with congestive heart failure on diuretic therapy, driven by pharmacokinetic and pharmacodynamic alterations.
Synapse has enriched 10 related papers. Consider them for comparative context: